Xiaoyun Liu - Betta Pharmaceut Co Ltd

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

BPI-501836: A Highly Potent Small Molecule Inhibitor Targeting KRASG12D Mutation

Xiang Yang, Yuan Lu, Renqi Xu,Xiaoqiang Kong, Yongqing Sun, Xingjie Zhu,Xiaoyun Liu,Zhengyao Zou,Haibo Chen, Yanju Liu, Jialing Sun, Han,Cheng Yang,Jing Guo,Hong Lan, Quan Zhou,Lieming Ding,Hao Wu,Jiabing Wang

Cancer Researchno. 6_Supplement (2024): 6512-6512

引用0浏览0引用

Development and Validation of a UPLC-MS/MS Method for Rapid and Simultaneous Quantification of BPI-460372 and Its Metabolites BPI-460444 and BPI-460456 in Human Plasma

Jianwei Ren,Hongzhong Liu,Yufang Ma, Wei Tian,Qinqin Li, Zhen Wu,Mengzhao Wang,Xiaoyun Liu,Xin Zheng,Xiaohong Han

Journal of Chromatography Bpp.124300-124300, (2024)

引用0浏览0WOS引用

Discovery and Characterization of a KRASG12C/D/V Degrader with Potent Anti-Tumor Activity in KRASmut-driven Preclinical Models

Zhengqing Li, Renqi Xu, Xiaofeng Yang,Zhengyao Zou,Xiaoqiang Kong,Haibo Chen, Yongqing Sun,Ying Zhao,Jing Guo, Cheng Yang, Han,Xiaoyun Liu,Hong Lan,Lieming Ding,Quan Zhou,Hao Wu,Jiabing Wang

Cancer Research（2024）

引用0浏览0引用

BPI-520105, a Highly Potent, CNS-penetrant 4th Generation EGFR Inhibitor Overcoming Major EGFR Resistance Mutations in NSCLC

Jing Guo,Lijia Liu,Xiangyong Liu,Bang Fu, Guangcan Bai,Changyong Qiu,Wei Ren,Xiaodong Song,Guolong Du,Xiao Sun, Yongchun Zhang, Weidong Cai, Pingping Wang,Haibo Chen,Xiaoyun Liu,Zhengyao Zou,Jiayu Zhao, Xuepeng Jv,Hong Lan,Lieming Ding,Jiabing Wang

Cancer Research（2024）

引用0浏览0引用

Discovery of a Potent Small Molecule MALT1 Protease Inhibitor for the Treatment of Cancer

Yuzhen Zhou,Bang Fu,Jie Chen, Weidong Cai,Xiao Sun,Yinlong Li,Wei Ren, Qichao Shen,Guolong Du,Xiaojun Zhou,Zhengyao Zou,Haibo Chen,Xiaoyun Liu,Cheng Yang,Xiangyong Liu,Jing Guo,Hao Wu,Lieming Ding,Jiabing Wang,Hong Lan

Cancer Researchno. 6_Supplement (2024): 7583-7583

引用0浏览0引用

BPI-511966,a Potent and Selective HPK1 Inhibitor with Robust Single-Agent Efficacy for Cancer Immunotherapy

Yong Zhang,Xiaoguan Zhu,Wenmao Wu, Zhifang Xia,Zhengyao Zou, Han,Cheng Yang,Haibo Chen,Tianyi Ma,Xiaoyun Liu,Jing Guo,Hao Wu,Hong Lan,Lieming Ding,Jiabing Wang, Quan Zhou

Cancer Researchno. 6_Supplement (2024): 6510-6510

引用0浏览0引用

BPI-452080: A Potent and Selective HIF-2α Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma, Von Hippel-Lindau Disease, and Other Solid Tumors

Pingping Wang, Rongwen Yang,Yun Sun,Xuepeng Ju,Jiayu Zhao,Yanju Liu,Xiaoyun Liu,Zhengyao Zou,Jialin Ren, Min Wang,Haibo Chen, Xuegang Yi,Jian Zhang,Teng Ma, Gaoliang Cheng,Lijia Liu,Jing Guo,Xiangyong Liu,Hong Lan,Lieming Ding,Jiabing Wang

CANCER RESEARCHno. 7 (2023)

引用1浏览0引用

BPI-472372: a Potent and Orally Bioavailable Small Molecule Inhibitor of CD73 for Cancer Immunotherapy

Han, Xiaofeng Yang, Ying Zhao, Jin Wang, Xiang Yang,Xuepeng Ju,Jiayu Zhao,Zhengyao Zou,Haibo Chen,Xiaoyun Liu,Jing Guo, Cheng Yang,Hong Lan,Hao Wu,Lieming Ding,Jiabing Wang

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Discovery of BPI-221351, a Potent, Selective, Orally Available, and Brain Penetrating Dual Inhibitor of Mutant IDH1/2

Hongling Shen,Xiaofeng Xu,Yabin Li,Xizhen Song,Jie Chen, Yunting Bi, Jing Guo, Tong Xu,Huijuan Zhang,Lijia Liu,Zhengyao Zou,Jialin Ren, Jun Tong,Xiaoyun Liu,Hongfei Rong,Teng Ma,Chao Wang,Xiangyong Liu,Hong Chen,Jiayu Zhao,Xuepeng Ju,Haibo Chen, Haidi Shen,Hong Lan,Lieming Ding,Jiabing Wang

Cancer Research（2023）

引用0浏览0引用

BPI-442096: A Potent and Selective Inhibitor of SHP2 for the Treatment of Multiple Cancers

Ling Li,Bang Fu, Han, Zhongxin Sun, Xiangdong Zhao, Xuepeng Jv, Jun Tong,Jiayu Zhao,Zhengyao Zou,Haibo Chen,Xiaoyun Liu,Wei Ren,Yinlong Li,Wenmao Wu,Jing Guo,Dan Yan,Xiangyong Liu,Hong Lan, Hao Wu,Lieming Ding,Jiabing Wang

Cancer Research（2022）

引用2浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn